Ahmad-Nejad P - Search Results

1

Response to letter: Device therapy and aldosterone antagonists in the prognosis of heart failure.

Behnes M, Bertsch T, Weiss C, Ahmad-Nejad P, Akin I, Fastner C, El-Battrawy I, Lang S, Neumaier M, Borggrefe M, Hoffmann U. Behnes M, et al. Int J Cardiol. 2016 Mar 15;207:391-2. doi: 10.1016/j.ijcard.2016.01.193. Epub 2016 Jan 21. Int J Cardiol. 2016. PMID: 26825668 No abstract available.

2

Methodologic European external quality assurance for DNA sequencing: the EQUALseq program.

Ahmad-Nejad P, Dorn-Beineke A, Pfeiffer U, Brade J, Geilenkeuser WJ, Ramsden S, Pazzagli M, Neumaier M. Ahmad-Nejad P, et al. Clin Chem. 2006 Apr;52(4):716-27. doi: 10.1373/clinchem.2005.061572. Epub 2006 Jan 26. Clin Chem. 2006. PMID: 16439604

3

Characterization and functional investigation of single nucleotide polymorphisms (SNPs) in the human TLR5 gene.

Merx S, Zimmer W, Neumaier M, Ahmad-Nejad P. Merx S, et al. Hum Mutat. 2006 Mar;27(3):293. doi: 10.1002/humu.9409. Hum Mutat. 2006. PMID: 16470719

4

Improvement of technical and analytical performance in DNA sequencing by external quality assessment-based molecular training.

Dorn-Beineke A, Ahmad-Nejad P, Pfeiffer U, Ramsden S, Pazzagli M, Neumaier M. Dorn-Beineke A, et al. Clin Chem. 2006 Nov;52(11):2072-8. doi: 10.1373/clinchem.2006.072405. Epub 2006 Sep 21. Clin Chem. 2006. PMID: 16990419

5

Characterization and investigation of single nucleotide polymorphisms and a novel TLR2 mutation in the human TLR2 gene.

Merx S, Neumaier M, Wagner H, Kirschning CJ, Ahmad-Nejad P. Merx S, et al. Hum Mol Genet. 2007 May 15;16(10):1225-32. doi: 10.1093/hmg/ddm070. Epub 2007 Apr 4. Hum Mol Genet. 2007. PMID: 17409197

6

Diagnostic performance and cost effectiveness of measurements of plasma N-terminal pro brain natriuretic peptide in patients presenting with acute dyspnea or peripheral edema.

Behnes M, Brueckmann M, Ahmad-Nejad P, Lang S, Wolpert C, Elmas E, Kaelsch T, Gruettner J, Weiss C, Borggrefe M, Neumaier M. Behnes M, et al. Int J Cardiol. 2009 Jun 26;135(2):165-74. doi: 10.1016/j.ijcard.2008.03.045. Epub 2008 Jul 7. Int J Cardiol. 2009. PMID: 18603317 Clinical Trial.

7

Plasminogen activator inhibitor-1 (PAI-1), toll-like receptor 4 (TLR4), factor II (FII), FXIII and fibrinogen polymorphisms are not associated with the prevalence of sudden death due to ventricular fibrillation during myocardial infarction.

Elmas E, Ahmad-Nejad P, Weiss C, Neumaier M, Borggrefe M. Elmas E, et al. Clin Chem Lab Med. 2008;46(9):1329-31. doi: 10.1515/CCLM.2008.265. Clin Chem Lab Med. 2008. PMID: 18785870 No abstract available.

8

Association of NT-proBNP with severity of heart valve disease in a medical patient population presenting with acute dyspnea or peripheral edema.

Behnes M, Lang S, Breithardt OA, Kaden JJ, Haghi D, Ahmad-Nejad P, Elmas E, Wolpert C, Borggrefe M, Neumaier M, Brueckmann M. Behnes M, et al. J Heart Valve Dis. 2008 Sep;17(5):557-65. J Heart Valve Dis. 2008. PMID: 18980090

9

The reduced anticoagulant effect of fondaparinux at low antithrombin levels.

Dempfle CE, Eichner J, Suvajac N, Ahmad-Nejad P, Neumaier M, Borggrefe M. Dempfle CE, et al. Anesth Analg. 2009 Sep;109(3):712-6. doi: 10.1213/ane.0b013e3181ae94b0. Anesth Analg. 2009. PMID: 19690236

10

Heptest-STAT, a new assay for monitoring of low-molecular-weight heparins, is not influenced by pregnancy-related changes of blood plasma.

Dempfle CE, Zharkowa U, Elmas E, Ahmad-Nejad P, Neumaier M, Borggrefe M. Dempfle CE, et al. Thromb Haemost. 2009 Nov;102(5):1001-6. doi: 10.1160/TH08-09-0560. Thromb Haemost. 2009. PMID: 19888540

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

62 results

Search Page

Filters